FDA Releases Video about Fosamax Dangers

The FDA released a video updating information regarding atypical femur fractures that have been associated with the use of bisphosphonates to treat osteoporosis.  (Fosamax, Actonel, Boniva, Atelvia, Reclast, and their generic equivalents.) Click here to watch the FDA Video Among the FDA recommendations to medical professionals are: • be aware of the possibility of atypical [...]

January 28th, 2011|Fosamax Osteoporosis Drug|0 Comments

Muni Derailments and Accidents on the Rise

The San Francisco MUNI system is a public railway depended on by thousands of people every day.  MUNI is an essential part of San Francisco, but lack of funding has caused recent problems: "In less than a week, five trains derailed at a Muni storage facility, a development operators say is due to a lack [...]

January 24th, 2011|MUNI and Public Transit|0 Comments

Avandia Maker Sets Aside $3.4 Billion for Lawsuits

British drug manufacturer GlaxoSmithKline (GSK), which makes the recalled diabetes drug Avandia, has set aside a $3.4 billion "to pay for United States government investigations and product liability cases over its marketing of" Avandia. Click here to read the entire New York Times article. This set aside is in addition to the $2.36 billion charge [...]

January 21st, 2011|Avandia Diabetes Drug|0 Comments

The FDA Identifies DePuy Hip Replacement Model Numbers

On October 13, 2010, the U.S. Food and Drug Administration released a report detailing the extent of DePuy's recall of its two metal-on-metal hip replacements, the ASL XL Acetabular System and the ASL Hip Resurfacing System.  (To see model numbers click here to go to the FDA Enforcement Report).  The report divides the recalled implants [...]

January 14th, 2011|DePuy Hip Replacement|0 Comments

Pharmaceutical Companies Perform Clinical Drug Trials in Other Countries

  "Prescription drugs kill some 200,000 Americans every year. Will that number go up, now that most clinical trials are conducted overseas...in places where regulation is virtually nonexistent, the F.D.A. doesn’t reach...?" A fascinating article recently discussed the increasingly common practice of  performing clinical drug trials outside of the United States for drugs planned to [...]

48.5% of Irish DePuy Patients Need to Replace their DePuy Hip

In August, DePuy Orthopaedics recalled its ASR XL total hip replacement device.  At that time, and up to today, DePuy has claimed that about 12% of people who have had the DePuy hip installed have or will need it to revised (removed and replaced with another product).  In fact, on its own website, DePuy continues [...]

January 10th, 2011|DePuy Hip Replacement|0 Comments

DePuy Paid Doctors over $60 Million in the Last 2 Years

One of the keys to drug and medical device manufacturers' sale of their products is articles by leading members in the profession that directly or indirectly extol the benefits of the product.  Manufacturers have long supported such “research”.  Some doctors will fairly disclose the amounts and the nature of their relationships so that the readers [...]

New Law Provides Vital Nursing Home Information

Do you have to make a decision for a parent or spouse regarding a nursing home? It is very difficult to get information that you can trust.  Talking with other families will often help, but interviewing the facility does not often lead to full disclosure regarding prior incidents, claims, or whether the facility has liability [...]

January 5th, 2011|Elder Abuse|0 Comments

Court Denies Avandia Manufacturer’s Request to Exclude Experts

This week, Honorable Cynthia M. Rufe of the U.S. District Court for the Eastern District of Pennsylvania rejected GlaxoSmithKline's (GSK) request to exclude three plaintiff experts from testifying about the health risks associated with taking the diabetes drug, Avandia. The national Avandia multidistrict litigation  is coordinated in front of Judge Rufe.  Multidistrict Litigation (MDL) is [...]

Drug Manufacturer Whistle-Blower Exposes Facility Failures

A segment on 60 Minutes discussed the story of Cheryl Eckard, who was the global quality assurance manager at GlaxoSmithKline (GSK).  Her job was to inspect plants to make sure drugs were manufactured properly and met government standards for purity. In 2002, Ms. Eckard was assigned to GSK's important Cidra, Puerto Rico, plant where 900 [...]

January 4th, 2011|Avandia Diabetes Drug|0 Comments